DeFloria Receives Investigational New Drug Application Clearance from FDA for Phase 2 Clinical Trial of AJA001, an Oral Cannabinoid Drug Being Developed for the Treatment of Autism Spectrum Disorder (ASD)

Stock Information for Charlottes Web Holdings Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Charlottes Web Holdings Inc

Charlotte's Web Reports Q3 2025 Results
Charlotte's Web Appoints M. Borgia Walker to Board of Directors
Charlotte's Web(TM) Expands its Brightside Line with Launch of Knockout Hemp THC Sleep Gummies
Charlotte's Web(TM) Expands Sleep Category with Launch of Quiet Sleep Mushroom Gummies
Charlotte's Web Announces Plans to Establish a Scientific Advisory Board
Aclarion Appoints Greg Gould as Chief Financial Officer
Charlotte's Web Reports Year-Over-Year Growth For Q2 2025
Charlotte's Web 2025 Second Quarter Earnings Call and Webcast Notice

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.